An Open Label, Non-Randomized, Single Dose, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2251052 Administered as a Single Intravenous Dose to Healthy Adult Subjects.
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Epetraborole (Primary)
- Indications Gram-negative infections; Intra-abdominal infections; Urinary tract infections
- Focus Pharmacokinetics
- Sponsors GSK
- 23 Nov 2011 New trial record